The best of these publish testing documents for the water itself, not just the peptides
Reusing a syringe, even for the same substance, is a massive contamination risk
The 2024 structural paper by the Wang group provides a side-by-side comparison with semaglutide and tirzepatide bound to their respective receptors
well-tolerated in mice, rats, rabbits, and dogs with no serious organ toxicity.[34][35] Clinical Safety : Mild local irritation possible at injection sites, but no systemic adverse effects reported in trials.[36][37] Potential Risks : Theoretical concerns include pro-angiogenic effects potentially promoting tumor growth, though no evidence supports this in studies.[38] Long-term human data is limited, so monitoring is advised
Furthermore, a concentration of SalB of less than 300 mg/kg won't harm pregnant rats